
Please try another search
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel.
Name | Age | Since | Title |
---|---|---|---|
Ellen S. Baron | 71 | 2020 | Independent External Director |
Efraim Cohen-Arazi | 69 | - | Independent Director |
Augustine J. Lawlor | 67 | 2020 | Independent External Director |
Ehud Geller | - | 2008 | Interim CEO & Executive Chairman |
Eli Hazum | - | 2012 | CTO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review